Evidence map›Paper›PMID 27591773›Full record

SynthesisJournal of neuro-oncology2016

Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis.

Nasser Alshehri, David J Cote, M Maher Hulou, Ahmad Alghamdi, Ali Alshahrani, Rania A Mekary, Timothy R Smith

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of neuro-oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 6 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 6 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Hypercoagulability in Cushing's syndrome: past, present, future.Archives of endocrinology and metabolism · 2025
    Review
  11. Article
  12. Article
  13. Cerebrovascular and Peripheral Vascular Complications in Cancer Patients.Current neurology and neuroscience reports · 2025
    Review
  14. Observational
  15. Evaluation of primary venous thromboembolism prophylaxis in hospitalized patients with primary brain tumors or secondary brain metastases.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nasser AlshehriMassachusetts College of Pharmacy and Health Sciences University, 17 Longwood Ave., Boston, MA, USA.
David J CoteCushing Neurosurgery Outcomes Center, Brigham and Women's Hospital, Department of Neurosurgery, Harvard Medical School, 15 Francis Street, Boston, MA, 02115, USA. david_cote@hms.harvard.edu.
M Maher HulouCushing Neurosurgery Outcomes Center, Brigham and Women's Hospital, Department of Neurosurgery, Harvard Medical School, 15 Francis Street, Boston, MA, 02115, USA.
Ahmad AlghamdiMassachusetts College of Pharmacy and Health Sciences University, 17 Longwood Ave., Boston, MA, USA.
Ali AlshahraniMassachusetts College of Pharmacy and Health Sciences University, 17 Longwood Ave., Boston, MA, USA.
Rania A MekaryMassachusetts College of Pharmacy and Health Sciences University, 17 Longwood Ave., Boston, MA, USA.
Timothy R SmithMassachusetts College of Pharmacy and Health Sciences University, 17 Longwood Ave., Boston, MA, USA.
MCPHS University · USBrigham and Women's Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumor patients undergoing craniotomy generally receive prophylaxis against venous thromboembolism (VTE), but modalities in use differ widely and have been debated in the literature. A systematic review and meta-analysis was conducted to assess the efficacy and safety of VTE prophylaxis among brain tumor patients undergoing craniotomy. Ten randomized controlled trials were included in the final efficacy analysis. The various prophylactic measures employed in these studies reduced the risk for thrombosis compared to controls with an overall risk ratio of 0.61 (95 % CI: 0.47-0.79) in the fixed effect model. Although Cochrane Q-test showed unimportant heterogeneity across studies (p = 0.19) and the I

Indexed as

Brain NeoplasmsCraniotomyFemaleHumansMalePostoperative ComplicationsVenous ThromboembolismBrain tumorCraniotomyHeparinMeta-analysisNeurosurgeryProphylaxisVenous thromboembolism

Identifiers

PMID27591773
OpenAlexW2514324902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.